Impaired lung vascular endothelial growth factor in extremely premature baboons developing bronchopulmonary dysplasia/chronic lung disease

Journal of Investigative Medicine

Volumn 53, Issue 5, 2005, Pages 253-263

  Tambunting, Francis ^a,b   Beharry, Kay D A ^a   Waltzman, Joshua ^b   Modanlou, Houchang D ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Division of Neonatology   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; NEUROPILIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BABOON; CHRONIC LUNG DISEASE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LUNG DYSPLASIA; LUNG FUNCTION; NONHUMAN; PATHOGENESIS; PREMATURITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; PAPIO; PAPIO HAMADRYAS;

EID: 23744459356     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2005.53508     Document Type: Article

References (33)

1. Aria E, Macdorman MF, Strobino DM, Guyer B. Annual summary of vital statistics-2002. Pediatrics 2003;112(6 Pt 1):1215-30.
2. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003;8:73-81.
3. Coalson JJ, Winter VT, Gertsmann DR, et al. Pathophysiologic, morphometric and biochemical studies of the premature baboon with bronchopulmonary displasia. Am Rev Respir Dis 1992;145:872-81.
4. Coalson JJ, Kuehl TJ, Escobedo MB, et al. A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol 1982;37:335-50.
5. Coalson JJ, Kuehl TJ, Prihoda TJ, deLemos RA. Diffuse alveolar damage in the evolution of bronchopulmonary dysplasia in the baboon. Pediatr Res 1988;24:357-66.
6. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with BPD. Am J Respir Crit Care Med 1995;152:640-6.
7. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-46.
8. Maniscalco WM, Watkins RH, Pryhuber GS, et al. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002;282:L811-23.
9. Ruhrberg C. Growing and shaping the vascular tree: multiple roles for VEGF. Bioessays 2003;25:1052-60.
10. Abman SH. Bronchopulmonary dysplasia. "A vascular hypothesis." Am J Respir Crit Care Med 2001;164:1755-6.
11. Bhatt AJ, Pryhuber GS, Huyck H, et al. Disrupted pulmonary vascular and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:1971-80.
12. Lassus P, Turanlahti M, Heikkila P, et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001;164:1981-7.
13. Ambalavanan N, Novak ZE. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr Res 2003;53:240-4.
14. D'Angio CT, Maniscalco WM. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci 2002;7:d1609-23.
15. Meyer KC, Cardoni AL, Xiang Z, et al. Vascular endothelial growth factor in human lung transplantation. Chest 2001;119:137-43.
16. Brown KRS, England KM, Goss KL, et al. VEGF induces airway cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001;281:L100-10.
17. Abman S. Vascular endothelial growth factor: not only for vessels anymore. Pediatr Res 2003;53:1.
18. Acarregui MJ, Penisten ST, Goss KL, et al. Vascular endothelial growth factor gene expression in human fetal lung in vitro. Am J Respir Cell Mol Biol 1999;20:14-23.
19. Maniscalco WM, Watkins RH, Finkelstein JN, Campbell MH. Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am J Respir Cell Mol Biol 1995;13:377-86.
20. Watkins RH, D'Angio CT, Ryan RM, et al. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol 1999;275(5 Pt 1):L858-67.
21. Grover TR, Parker TA, Zenge JP, et al. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2003;284:L508-17.
22. Ikeda M, Hosoda Y, Hirose S, et al. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissue of rheumatoid arthritis. J Pathol 2000;191:426-33.
23. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 2001;26: 25-35.
24. Hiratsuka S, Mam Y, Okada A, et al. Involvement of Flt-1 tyrosinase kinase (vascular endothelial growth factor receptor-1) in pathologic angiogenesis. Cancer Res 2001;61:1207-13.
25. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-6.
26. Roeckl W, Hecht D, Sztajer H, et al. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 1998;241:161-70.
27. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 1993;15;90:10705-9.
28. Knox AJ, Corbett L, Stocks J, et al. Human airway smooth muscle cells secrete vascular endothelial growth factor: upregulation by bradykinin via a protein kinase C and prostanoids-dependent mechanism. FASEB J 2001;15:2480-8.
29. Witzenbichler B, Asahara T, Murohara T, et al. Vascular endothelial growth factor-C (VEGF-C/VEFG-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998;153:381-94.
30. Bhatt AJ, Amin SB, Chess PR, et al. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 2000;47:606-13.
31. Maniscalco WM, Watkins RH, D'Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 1997;16:557-67.
32. Greenberg JM, Thompson FY, Brooks SK, et al. Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung. Dev Dyn 2002;224:144-53.
33. Das KC, Ravi D, Holland W. Increased apoptosis and expression of p21 and p53 in premature infant baboon model of bronchopulmonary dysplasia. Antioxid Redox Signal 2004;6:109-16.